The Efficacy of Suvorexant in the Residential Treatment of Patients With Substance Use Disorder and Insomnia: A Pilot Open Trial
Phase of Trial: Phase II/III
Latest Information Update: 28 May 2018
At a glance
- Drugs Suvorexant (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- Acronyms Suvsubuse
- 31 Aug 2018 Biomarkers information updated
- 17 May 2018 Planned End Date changed from 30 Mar 2019 to 14 Jun 2019.
- 17 May 2018 Planned primary completion date changed from 30 Mar 2019 to 14 Jun 2019.